COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 6,350.00
+26.00 (0.41%)
Oct 23, 2026, 3:30 PM JST
COSMOS Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Revenue Revenue Growth | 1,113,842 | 1,099,583 | 1,011,390 | 964,989 | 827,697 | 755,414 |
Revenue Growth | 8.99% | 8.72% | 4.81% | 16.59% | 9.57% | 3.99% |
Gross Profit Gross Profit Growth | 234,638 | 229,683 | 213,281 | 188,306 | 168,718 | 151,448 |
Operating Income Operating Income Growth | 42,259 | 42,353 | 40,404 | 31,502 | 30,129 | 29,797 |
Net Income Net Income Growth | 32,126 | 32,046 | 30,978 | 24,454 | 23,797 | 23,155 |
Earnings Per Share EPS Growth | 405.34 | 404.33 | 390.85 | 308.61 | 300.48 | 292.37 |
EPS Growth | 3.61% | 3.45% | 26.65% | 2.71% | 2.77% | -14.73% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Investments Cash & Investments Growth | 39,375 | 61,341 | 57,038 | 52,301 | 45,928 | 37,362 |
Total Debt Total Debt Growth | 68,477 | 78,476 | 49,957 | 34,063 | 18,201 | 9,413 |
Net Cash (Debt) Net Cash Growth | -29,102 | -17,135 | 7,081 | 18,238 | 27,727 | 27,949 |
Net Cash Growth | - | - | -61.17% | -34.22% | -0.79% | -37.42% |
Net Cash Per Share Net Cash Per Share Growth | -367.18 | -216.19 | 89.34 | 230.16 | 350.10 | 352.90 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 58,790 | 52,467 | 55,175 | 54,434 | 32,194 |
Capital Expenditures CapEx Growth | - | -70,462 | -53,326 | -55,810 | -46,636 | -43,497 |
Free Cash Flow Free Cash Flow Growth | - | -11,672 | -859 | -635 | 7,798 | -11,303 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Gross Margin | 21.07% | 20.89% | 21.09% | 19.51% | 20.38% | 20.05% |
Operating Margin | 3.79% | 3.85% | 4.00% | 3.26% | 3.64% | 3.94% |
Pretax Margin | 3.99% | 4.02% | 4.19% | 3.49% | 3.96% | 4.37% |
Profit Margin | 2.88% | 2.91% | 3.06% | 2.53% | 2.88% | 3.06% |
FCF Margin | - | -1.06% | -0.08% | -0.07% | 0.94% | -1.50% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 84.000 | 82.000 | 70.000 | 60.000 | 50.000 | 40.000 |
Dividend Per Share Growth | 15.33% | 17.14% | 16.67% | 20.00% | 25.00% | 14.29% |
Dividend Yield | 1.32% | 1.36% | 0.79% | 0.95% | 0.75% | 0.66% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 15.67 | 14.87 | 22.60 | 20.57 | 22.07 | 20.86 |
Forward PE | 15.42 | 14.54 | 21.94 | 19.07 | 21.97 | 19.33 |
P/FCF Ratio | - | - | - | - | 67.33 | - |
PS Ratio | 0.45 | 0.43 | 0.69 | 0.52 | 0.63 | 0.64 |